期刊文献+

骨髓增生异常综合征患者骨髓铁调素水平的研究 被引量:3

Study of hepcidin level in bone marrow in patients with myelodysplastic syndromes
下载PDF
导出
摘要 目的研究铁调素及其相关因素对骨髓增生异常综合征(MDS)患者铁过载水平的评估价值。方法选取64例MDS患者,采用ELISA法对患者的外周血和骨髓铁调素水平进行测定;Real-Time PCR法测定骨髓生长分化因子15(GDF15)和扭转原肠胚形成同系物1(TWSG1)mRNA的表达;流式细胞仪对T淋巴细胞亚型(CD4^+、CD19^+)和极化进行测定;采用磁共振成像T2~*(MRI T2~*)技术对心脏和肝脏铁沉积程度进行测定;结合患者的血清铁蛋白(SF)、C反应蛋白(CRP)和促红细胞生成素(EPO)资料,对数据进行分析。结果 64例MDS患者外周血与骨髓的铁调素表达水平无明显差异(P=0.134)。根据WHO 2008分型分组,难治性贫血伴环形铁粒幼细胞增多(RARS)亚型的骨髓铁调素表达水平最低[(105.40±5.13)ng/mL],难治性贫血伴原始细胞增多(RAEB)亚型的骨髓铁调素表达水平最高[(335.71±25.16)ng/mL],各组间比较差异有统计学意义(P=0.041)。根据IPSS积分和WPSS积分分组,低危组和高危组骨髓铁调素表达水平比较差异均有统计学意义(P<0.05和P<0.01);但与WPSS低危组相比,WPSS高危组的SF和GDF15 mRNA均明显高表达(P<0.05),而IPSS低危组与高危组比较差异无统计学意义(P>0.05)。根据T淋巴细胞亚型和极化分组,CD4^+高表达组骨髓铁调素水平较正常组高(P<0.05);CD19^+高表达和正常组间骨髓铁调素水平比较无统计学意义(P=0.206);Th1/Th2>70.6组骨髓铁调素水平高于Th1/Th2≤70.6组(P<0.001)。将铁调素与SF、心脏T2~*值、肝脏铁浓度(LIC)(由肝脏T2~*值换算得到)做逐步回归分析,仅有LIC水平与铁调素存在相关性(r=0.582,P<0.001)。结论炎症对于调节铁调素表达至关重要,T淋巴细胞的活化及极化趋势可能在其中起到部分作用。MRI T2~*对于评估MDS患者铁过载水平的效能优于SF。 Objective To determine the role of hepcidin and related factors in evaluation of iron overload in patients with myelodysplastic syndromes (MDS). Methods Sixty-four patients with MDS were enrolled. The hepcidin levels in peripheral blood and bone marrow were measured by ELISA, the expression of growth differentiation factor 15 (GDF15) and twisted gastrulation 1 (TWSG1) mRNA was detected by Real-Time PCR, T lymphocyte subtypes (CD4~ and CD19+ lymphocytes) and T lymphocyte polarization were determined by flow cytometry, the deposition of iron in heart and liver was examined through magnetic resonance imaging T2" ( MRI T2" ), and serum ferritin (SF), C-reactive protein (CRP) and erythropoietin (EPO) levels were measured. Results There was no significant difference between hepcidin level in peripheral blood and that in bone marrow (P = 0. 134). Stratified according to WHO 2008 subtypes, the hepcidin level in patients with refractory anemia with ringed sideroblasts (RARS) was the lowest [ ( 105.40 + 5.13) ng/mL], and that in patients with refractory anemia with excess blasts (RAEB) was the highest [ (335.71 + 25.16) ng/mL], and there were significant differences among groups (P = O. 041). Stratified according to IPSS and WPSS, there were significant differences in hepcidin levels between low-risk group and high-risk group in two systems respectively (P 〈 O. 05 and P 〈 0.01). The SF level and expression of GDF15 mRNA in WPSS high-risk group were significantly higher than those in WPSS low-risk group (P 〈0.05), while there was no significant difference between IPSS low-risk group and IPSS high-risk group (P 〉 0.05).Stratified according to T lymphocyte subtype and polarization, than that in normal expression group ( P 〈 0, 05), but there the hepcidin level in CD4 ~ high-expression group was higher was no significant difference in the hepcidin levels between CD19 * high-expression group and normal expression group (P = 0. 206)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第1期56-61,66,共7页 Journal of Shanghai Jiao tong University:Medical Science
关键词 铁调素 炎症 磁共振成像T2* hepcidin inflammation magnetic resonance imaging T2*
  • 相关文献

参考文献28

  • 1Tefferi A,Vardiman JV. Myelodysplastic syndromes[J].New England Journal of Medicine,2009,(19):1872-1885. 被引量:1
  • 2Mahesh S,Ginzburg Y,Verma A. Iron overload in myelodysplastic syndromes[J].Leukemia and Lymphoma,2008,(03):427-438. 被引量:1
  • 3Tanno T,Miller JL. Iron loading and overloading due to ineffective erythropoiesis[J].Adv Hematol,2010.358283. 被引量:1
  • 4Gattermann N,Rachmilewitz EA. Iron overload in MDS-pathophysiology,diagnosis,and complications[J].Annals of Hematology,2011,(01):1-10. 被引量:1
  • 5Ganz T,Nemeth E. Hepcidin and disorders of iron metabolism[J].Annual Review of Medicine,2011.347-360. 被引量:1
  • 6Nemeth E. Iron regulation and erythropoiesis[J].Current Opinion in Hematology,2008,(03):169-175. 被引量:1
  • 7Tanno T,Noel P,Miller JL. Growth differentiation factor 15 in erythroid health and disease[J].Current Opinion in Hematology,2010,(03):184-190. 被引量:1
  • 8Tanno T,Bhanu NV,Oneal PA. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin[J].Nature Medicine,2007,(09):1096-1101. 被引量:1
  • 9Tanno T,Porayette P,Sripichai O. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells[J].Blood,2009,(01):181-186. 被引量:1
  • 10Pinto JP,Dias V,Zoller H. Hepcidin messenger RNA expression in human lymphocytes[J].Immunology,2009,(02):217-230. 被引量:1

二级参考文献15

  • 1王秀丽,邵宗鸿,姚程,何广胜,刘鸿,施均,白洁,曹燕然,涂梅峰,王化泉,邢莉民,孙娟,贾海蓉,杨崇礼.骨髓增生异常综合征患者骨髓T辅助细胞亚群的研究[J].中华血液学杂志,2005,26(12):743-745. 被引量:17
  • 2Shimamoto T, Tohyama K, Okamoto T, et al. Cyclosporin A therapy for patients with myelodysplastic syndrome: muhicenter pilot studies in Japan. Leuk Res, 2003, 27: 783-788. 被引量:1
  • 3Stadler M, Germing U, Kliche KO, et al. A prospective, randomised, phase Ⅱ study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with lowrisk myelodysplastic syndromes. Leukemia, 2004, 18: 460-465. 被引量:1
  • 4Harris N, Jaffe E, Diebold J, et al. WHO classification of neoplastic diseases of the hematopietic and lymphoid tissues: report of the Clinical Advisory Committee meeting Article House, Virginia, November 1997. J Clin Oncol, 1999, 17: 3835-3849. 被引量:1
  • 5Greenberg P, Cox C, Le Beau MM, et al. International scoring systerm (IPSS) for evaluating prognosis in myelodysplastic syndrome. Blood, 1997, 89: 2079-2088. 被引量:1
  • 6Invernizzi R, Pecci A, Bellotti L, et al. Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes. Leuk Lymphoma, 2001, 42: 481-489. 被引量:1
  • 7Yazji S, Gile FJ, Tsimberidou AM, et al. Antithymocyte globulin (ATG) based therapy in patients with myelodysplastic syndromes. Leukemia, 2003, 17 : 2101-2106. 被引量:1
  • 8Romagnami S. Human Th1 and Th2 subsets: doubt no more. Immunol Today, 1991, 12: 256-257. 被引量:1
  • 9Tsuda H, Yamasaki H. Type I and type Ⅱ T-cell profiles in aplastic anemia and refractory anemia. Am J Hematol, 2000, 64: 271-274. 被引量:1
  • 10Li X, Bryant CE, Deeg HJ. Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome. Int J Hematol, 2004, 80: 140-145. 被引量:1

共引文献3

同被引文献12

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部